September 2016
Volume 57, Issue 12
ARVO Annual Meeting Abstract  |   September 2016
Uveitis in pregnancy
Author Affiliations & Notes
  • Lyndell L Lim
    Centre for Eye Research Australia, University of Melbourne, Melbourne, Victoria, Australia
  • Footnotes
    Commercial Relationships   Lyndell Lim, Abbvie (R), Allergan (R), Bayer (R), Bayer (F), Novartis (F)
  • Footnotes
    Support  Diabetes Australia Research Trust Grant 2015
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lyndell L Lim; Uveitis in pregnancy. Invest. Ophthalmol. Vis. Sci. 2016;57(12):No Pagination Specified.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Presentation Description : Pregnancy is associated with various hormonal and immunological changes that facilitate the survival of the semi-allogenic foetus. These physiological changes influence the course of various maternal autoimmune diseases, including uveitis. Given that uveitis has a peak incidence in young adults, it is not uncommon for female patients with known uveitis to become pregnant. As many treatments for uveitis may have detrimental side effects on the developing foetus, knowledge regarding the prognosis of these patients’ eye disease during pregnancy will have important implications on their management. This talk will discuss the effect of pregnancy on the course of uveitis, based upon published clinical studies in the field, and how this effect may vary depending on the type of uveitis the patient may have.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.